NCT06183437 2026-03-30
STOP-MED CTRCD
University Health Network, Toronto
Phase 4 Recruiting
Clinical Trials
8 trialsNCT04928261 2026-01-22
Evaluating 6-months of HER2-targeted Therapy in Patients With HER2 Positive Early-stage Breast Cancer That Achieve a Pathological Complete Response to Neoadjuvant Systemic Therapy
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT02696707 2025-12-18
OTT 15-05
Ottawa Hospital Research Institute
Phase 4 Completed
NCT07254221 2025-12-10
ROSUBREAST
Shiraz University of Medical Sciences
Phase 4 Not yet recruiting
NCT05465031 2025-03-14
Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
Silesian Centre for Heart Diseases
Phase 4 Recruiting
NCT04939883 2024-06-28
CardioTox
Hospital Sirio-Libanes
Phase 4 Unknown
NCT06005259 2023-08-22
SPIROTOX
University of Sao Paulo
Phase 4 Unknown
NCT04434404 2020-06-16
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Phase 4 Completed